Deniz Gökengin1, Fardad Doroudi2, Johnny Tohme3, Ben Collins4, Navid Madani5. 1. Department of Clinical Microbiology and Infectious Diseases, Medical Faculty, Ege University, Bornova, Izmir, Turkey. Electronic address: deniz.gokengin@ege.edu.tr. 2. UNAIDS - The Joint United Nations Programme on HIV/AIDS (UNAIDS), Islamic Republic of Iran. Electronic address: DoroudiF@unaids.org. 3. M-Coalition, Yazbeck Center, Achrafieh, Beirut, Lebanon. Electronic address: jtohme@afemena.org. 4. International HIV Partnerships, London, UK. Electronic address: bc@ihp.hiv. 5. Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: navid_madani@dfci.harvard.edu.
Abstract
OBJECTIVES: To give an overview of the HIV epidemic in the Middle East and North Africa (MENA) region. METHODS: Articles on the MENA region were reviewed. RESULTS: The MENA region comprises a geographically defined group of countries including both high-income, well-developed nations and low- and middle-income countries. While the annual number of new HIV infections in Sub-Saharan Africa has declined by 33% since 2005, new HIV infections in the MENA region have increased by 31% since 2001, which is the highest increase among all regions in the world. Moreover, the number of AIDS-related deaths in 2013 was estimated to be 15000, representing a 66% increase since 2005. However, the current prevalence of 0.1% is still among the lowest rates globally. There is substantial heterogeneity in HIV epidemic dynamics across MENA, and different risk contexts are present throughout the region. Despite unfavorable conditions, many countries in the region have put significant effort into scaling up their response to this growing epidemic, while in others the response to HIV is proving slower due to denial, stigma, and reluctance to address sensitive issues. CONCLUSIONS: The HIV epidemic in the MENA region is still at a controllable level, and this opportunity should not be missed.
OBJECTIVES: To give an overview of the HIV epidemic in the Middle East and North Africa (MENA) region. METHODS: Articles on the MENA region were reviewed. RESULTS: The MENA region comprises a geographically defined group of countries including both high-income, well-developed nations and low- and middle-income countries. While the annual number of new HIV infections in Sub-Saharan Africa has declined by 33% since 2005, new HIV infections in the MENA region have increased by 31% since 2001, which is the highest increase among all regions in the world. Moreover, the number of AIDS-related deaths in 2013 was estimated to be 15000, representing a 66% increase since 2005. However, the current prevalence of 0.1% is still among the lowest rates globally. There is substantial heterogeneity in HIV epidemic dynamics across MENA, and different risk contexts are present throughout the region. Despite unfavorable conditions, many countries in the region have put significant effort into scaling up their response to this growing epidemic, while in others the response to HIV is proving slower due to denial, stigma, and reluctance to address sensitive issues. CONCLUSIONS: The HIV epidemic in the MENA region is still at a controllable level, and this opportunity should not be missed.
Authors: Mohammad Karamouzian; Hamid Sharifi; Mehrdad Khezri; Mostafa Shokoohi; Ali Mirzazadeh; Fatemeh Tavakoli; Nima Ghalekhani; Ghazal Mousavian; Soheil Mehmandoost; Parvin Afsar Kazerooni; Ali Akbar Haghdoost Journal: AIDS Behav Date: 2022-02-23
Authors: Mohammad Amin Ghatee; Hossein Mirhendi; Mehdi Karamian; Walter R Taylor; Iraj Sharifi; Massood Hosseinzadeh; Zahra Kanannejad Journal: Parasitol Res Date: 2018-08-13 Impact factor: 2.289
Authors: Sana Eybpoosh; Abbas Bahrampour; Mohammad Karamouzian; Kayhan Azadmanesh; Fatemeh Jahanbakhsh; Ehsan Mostafavi; Farzaneh Zolala; Ali Akbar Haghdoost Journal: PLoS One Date: 2016-06-09 Impact factor: 3.240